Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Mori, Takuya
NCT04239950: Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia	Active, not recruiting	3	300	RoW	Placebo, Ethyl Icosapentate	Mochida Pharmaceutical Company, Ltd., Sumitomo Pharma (Suzhou) Co., Ltd.	Hypertriglyceridemia	12/23	12/23